{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T01:05:40Z","timestamp":1788397540545,"version":"build-2803163510"},"reference-count":61,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.clinthera.2009.08.015","type":"journal-article","created":{"date-parts":[[2009,10,6]],"date-time":"2009-10-06T08:47:47Z","timestamp":1254818867000},"page":"1664-1687","source":"Crossref","is-referenced-by-count":30,"title":["Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children"],"prefix":"10.1016","volume":"31","author":[{"given":"Devada","family":"Singh-Franco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoytin Lee","family":"Ghin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela I.","family":"Robles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Borja-Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl","key":"10.1016\/j.clinthera.2009.08.015_bib1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2008.06.003","article-title":"The diagnosis and management of rhinitis: An updated practice parameter [published correction appears in J Allergy Clin Immunol. 2008;122:1237]","volume":"122","author":"Wallace","year":"2008","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.clinthera.2009.08.015_bib2","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1067\/mjd.2002.122759","article-title":"Chronic urticaria","volume":"46","author":"Grattan","year":"2002","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.clinthera.2009.08.015_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1081-1206(10)60438-3","article-title":"Differential diagnosis of chronic urticaria","volume":"100","author":"Brodell","year":"2008","journal-title":"Ann Allergy Asthma Immunol."},{"key":"10.1016\/j.clinthera.2009.08.015_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1081-1206(10)60617-5","article-title":"Psychiatric morbidity and quality of life in patients with chronic idiopathic urticaria","volume":"99","author":"Ozkan","year":"2007","journal-title":"Ann Allergy Asthma Immunol."},{"key":"10.1016\/j.clinthera.2009.08.015_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/archdermatol.2007.5","article-title":"Annual direct and indirect health care costs of chronic idiopathic urticaria: A cost analysis of 50 nonimmunosuppressed patients","volume":"144","author":"Delong","year":"2008","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.clinthera.2009.08.015_bib6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1081-1206(10)60462-0","article-title":"Therapeutic alternatives for chronic urticaria: An evidence-based review, Part 1","volume":"100","author":"Morgan","year":"2008","journal-title":"Ann Allergy Asthma Immunol."},{"key":"10.1016\/j.clinthera.2009.08.015_bib7","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1081-1206(10)60047-6","article-title":"Therapeutic alternatives for chronic urticaria: An evidence-based review, Part 2","volume":"100","author":"Morgan","year":"2008","journal-title":"Ann Allergy Asthma Immunol."},{"key":"10.1016\/j.clinthera.2009.08.015_bib8","series-title":"Xyzal [package insert]","year":"2008"},{"key":"10.1016\/j.clinthera.2009.08.015_bib9","series-title":"Pharmacotherapy: A Pathophysiologic Approach","first-page":"1565","article-title":"Allergic rhinitis","author":"May","year":"2008"},{"key":"10.1016\/j.clinthera.2009.08.015_bib10","series-title":"Goodman & Oilman's The Pharmacological Basis of Therapeutics","first-page":"581","article-title":"Histamine, bradykinin, and their antagonists","author":"Babe","year":"1996"},{"key":"10.1016\/j.clinthera.2009.08.015_bib11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.pharmthera.2007.01.012","article-title":"Allergic rhinitis and its pharmacology","volume":"114","author":"Al Suleimani","year":"2007","journal-title":"Pharmacol Ther."},{"key":"10.1016\/j.clinthera.2009.08.015_bib12","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0194-5998(03)00601-6","article-title":"The role of leukotrienes in nasal allergy","volume":"129","author":"Haberal","year":"2003","journal-title":"Otolaryngol Head Neck Surg."},{"key":"10.1016\/j.clinthera.2009.08.015_bib13","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000236855","article-title":"Correlations between complaints, inflammatory cells and mediator concentrations in nasal secretions after nasal allergen challenge and during natural allergen exposure","volume":"106","author":"Wang","year":"1995","journal-title":"Int Arch Allergy Immunol."},{"key":"10.1016\/j.clinthera.2009.08.015_bib14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jaci.2005.09.047","article-title":"Severity and impairment of allergic rhinitis in patients consulting in primary care","volume":"117","author":"Bousquet","year":"2006","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.clinthera.2009.08.015_bib15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1081-1206(10)60588-1","article-title":"Pathophysiology of chronic urticaria","volume":"100","author":"Bordell","year":"2008","journal-title":"Ann Allergy Asthma Immunol."},{"key":"10.1016\/j.clinthera.2009.08.015_bib16","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0190-9622(99)70495-0","article-title":"Chronic idopathic urticaria: Comparison of the clinical features of patients with and without anti-FcepsilonRI or anti-IgE autoanti-bodies","volume":"40","author":"Sabroe","year":"1999","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.clinthera.2009.08.015_bib17","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1346-8138.2007.00276.x","article-title":"Chronic idiopathic urticaria: Prevalence and clinical course","volume":"34","author":"Kulthanan","year":"2007","journal-title":"J Dermatol."},{"key":"10.1016\/j.clinthera.2009.08.015_bib18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000083104","article-title":"Urticaria","volume":"5","author":"Raap","year":"2004","journal-title":"Dermatol Psychosom."},{"key":"10.1016\/j.clinthera.2009.08.015_bib19","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/SMJ.0b013e3181611bc8","article-title":"Treatment options for the relief of chronic idio-pathic urticaria symptoms","volume":"101","author":"Fromer","year":"2008","journal-title":"South MedJ."},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2009.08.015_bib20","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1007\/PL00022458","article-title":"Major role for the carboxylic function of cetirizine and levocetirizine in their binding characteristics to human H1-histamine-receptors","volume":"51","author":"Gillard","year":"2002","journal-title":"Inflamm Res."},{"key":"10.1016\/j.clinthera.2009.08.015_bib21","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/sj.bjp.0707318","article-title":"Peripheral and central H1 histamine receptor occupancy by levocetirizine, a non-sedating anti-histamine: A time-course study in the guinea pig","volume":"151","author":"Gupta","year":"2007","journal-title":"Br J Pharmacol."},{"key":"10.1016\/j.clinthera.2009.08.015_bib22","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1046\/j.1365-2745.2002.01444.x","article-title":"Cetirizine and levocetirizine inhibit eotaxin-induced eosinophil transendothelial migration through human dermal or lung microvascular endothelial cells","volume":"32","author":"Thomson","year":"2002","journal-title":"Clin Exp Allergy."},{"key":"10.1016\/j.clinthera.2009.08.015_bib23","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/j.1365-2222.2004.01960.x","article-title":"Levocetirizine improves nasal obstruction and modulates cytokine pattern in patients with seasonal allergic rhinitis: A pilot study","volume":"34","author":"Ciprandi","year":"2004","journal-title":"Clin Exp Allergy."},{"key":"10.1016\/j.clinthera.2009.08.015_bib24","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s002280100364","article-title":"Absorption, distribution, metabolism and excretion of [14C]levocetirizine, the R enantiomer of cetirizine, in healthy volunteers","volume":"57","author":"Strolin Benedetti","year":"2001","journal-title":"Eur J Clin Pharmacol."},{"key":"10.1016\/j.clinthera.2009.08.015_bib25","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1046\/j.1472-8206.2002.00111.x","article-title":"Blood distribution of levocetirizine, a new non-sedating histamine H1-receptor antagonist, in humans","volume":"16","author":"Bree","year":"2002","journal-title":"Fundam Clin Pharmacol."},{"key":"10.1016\/j.clinthera.2009.08.015_bib26","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jaci.2005.04.010","article-title":"Levocetirizine: Pharmacokinetics and pharmacodynamics in children age 6 to 11 years","volume":"116","author":"Simons","year":"2005","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.clinthera.2009.08.015_bib27","doi-asserted-by":"crossref","first-page":"172","DOI":"10.5414\/CPP43172","article-title":"Levocetirizine in 1\u20132 year old children: Pharmacokinetic and pharmacodynamic profile","volume":"43","author":"Cranswick","year":"2005","journal-title":"Int J Clin Pharmacol Ther."},{"key":"10.1016\/j.clinthera.2009.08.015_bib28","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1399-3038.2005.00240.x","article-title":"Population pharmacokinetics of levocetirizine in very young children: The pediatricians' perspective","volume":"16","author":"Simons","year":"2005","journal-title":"Pediatr Allergy Immunol."},{"key":"10.1016\/j.clinthera.2009.08.015_bib29","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1365-2125.2005.02242.x","article-title":"Retrospective population pharmacokinetics of levocetirizine in atopic children receiving cetirizine: The ETAC study","volume":"59","author":"Hussein","year":"2005","journal-title":"Br J Clin Pharmacol."},{"key":"10.1016\/j.clinthera.2009.08.015_bib30","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S1081-1206(10)61995-3","article-title":"A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolas-tine, and placebo: Suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects","volume":"88","author":"Grant","year":"2002","journal-title":"Ann Allergy Asthma Immunol."},{"key":"10.1016\/j.clinthera.2009.08.015_bib31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00011-006-0075-z","article-title":"A comparison of levocetirizine and desloratadine in the histamine-induced wheal and flare response in human skin in vivo","volume":"55","author":"Popov","year":"2006","journal-title":"Inflamm Res"},{"key":"10.1016\/j.clinthera.2009.08.015_bib32","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2340\/00015555-0085","article-title":"Levocetirizine for treatment of immediate and delayed mosquito bite reactions","volume":"86","author":"Karppinen","year":"2006","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clinthera.2009.08.015_bib33","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2125.2004.02110.x","article-title":"Single and short-term dosing effects of levocetirizine on adenosine monophosphate bronchoprovocation in atopic asthma","volume":"58","author":"Lee","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2009.08.015_bib34","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2222.1991.tb00807.x","article-title":"Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis","volume":"21","author":"Juniper","year":"1991","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.clinthera.2009.08.015_bib35","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1046\/j.1365-2222.2000.00668.x","article-title":"Development and validation of the mini Rhinoconjuncti-vitis Quality of Life Questionnaire","volume":"30","author":"Juniper","year":"2000","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.clinthera.2009.08.015_bib36","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0091-6749(98)70380-X","article-title":"Measuring quality of life in children with rhinoconjunctivitis","volume":"101","author":"Juniper","year":"1998","journal-title":"J Alleg Clin Immunol"},{"key":"10.1016\/j.clinthera.2009.08.015_bib37","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1034\/j.1398-9995.2003.00079.x","article-title":"Rhinasthma: A new specific QoL questionnaire for patients with rhinitis and asthma","volume":"58","author":"Baiardini","year":"2003","journal-title":"Allergy"},{"key":"10.1016\/j.clinthera.2009.08.015_bib38","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI)\u2014a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clinthera.2009.08.015_bib39","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1034\/j.1398-9995.2003.00171.x","article-title":"Levocetirizine is effective for symptom relief including nasal congestion in adolescent and adult (PAR) sensitized to house dust mites","volume":"58","author":"Potter","year":"2003","journal-title":"Allergy"},{"key":"10.1016\/j.clinthera.2009.08.015_bib40","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1081-1206(10)61208-2","article-title":"Efficacy and safety of levocetirizine on symptoms and health-related quality of life of children with perennial allergic rhinitis: A double-blind, placebo-controlled randomized clinical trial","volume":"95","author":"Potter","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.clinthera.2009.08.015_bib41","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jaci.2004.05.070","article-title":"Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis","volume":"114","author":"Bachert","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinthera.2009.08.015_bib42","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.rmed.2006.03.039","article-title":"Levocetirizine improves health-related quality of life and health status in persistent allergic rhinitis","volume":"100","author":"Canonica","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.clinthera.2009.08.015_bib43","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1027\/0838-1925.19.1.4","article-title":"Long-term treatment of persistent allergic rhinitis with levocetirizine: Improvements in activity and sleep items of the Rhinoconjuncti-vitis Quality of Life Questionnaire (RQLQ)","volume":"19","author":"Klimek","year":"2007","journal-title":"Allergy Clin Immunol Int\u2014J World Allergy Org"},{"key":"10.1016\/j.clinthera.2009.08.015_bib44","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.intimp.2005.05.008","article-title":"Desloratadine and levocetiri-zine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: A pilot study","volume":"5","author":"Ciprandi","year":"2005","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.clinthera.2009.08.015_bib45","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S1081-1206(10)61098-8","article-title":"Montelu- kast with desloratadine or levoceti-rizine for the treatment of persistent allergic rhinitis","volume":"97","author":"Ciebiada","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.clinthera.2009.08.015_bib46","first-page":"343","article-title":"Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetiri-zine or desloratadine","volume":"18","author":"Ciebiada","year":"2008","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.clinthera.2009.08.015_bib47","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1185\/03007990802395927","article-title":"Levo-cetirizine in persistent allergic rhinitis: Continuous or on-demand use? A pilot study","volume":"24","author":"Canonica","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2009.08.015_bib48","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1399-3038.2005.00216.x","article-title":"Levocetirizine in children: Evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial","volume":"16","author":"de Blic","year":"2005","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.clinthera.2009.08.015_bib49","first-page":"55","article-title":"Levocetirizine as treatment for symptoms of seasonal allergic rhinitis","volume":"2","author":"Jorissen","year":"2006","journal-title":"B-ENT"},{"key":"10.1016\/j.clinthera.2009.08.015_bib50","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1365-2222.2006.02478.x","article-title":"Effects of levocetirizine as add-on therapy to fluticasone in seasonal allergic rhinitis","volume":"36","author":"Barnes","year":"2006","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.clinthera.2009.08.015_bib51","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2133.2005.07049.x","article-title":"Levocetirizine in the treatment of chronic idiopathic urticaria: A randomized, double-blind, placebo-controlled study","volume":"154","author":"Nettis","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clinthera.2009.08.015_bib52","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-4632.2005.02609.x","article-title":"Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: A randomized, double-blind, placebo-controlled, parallel, multicenter study","volume":"45","author":"Kapp","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clinthera.2009.08.015_bib53","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1398-9995.2008.01893.x","article-title":"Comparison of the efficacy of levo-cetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients","volume":"64","author":"Potter","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.clinthera.2009.08.015_bib54","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/09546630601028745","article-title":"Comparative efficacy of cetirizine and levocetiri-zine in chronic idiopathic urticaria","volume":"18","author":"Garg","year":"2007","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clinthera.2009.08.015_bib55","first-page":"897","article-title":"Comparison of the risk of drowsiness and sedation between levocetirizine and desloratadine: A prescription-event monitoring study in England","volume":"29","author":"Layton","year":"2006","journal-title":"DrugSaf"},{"key":"10.1016\/j.clinthera.2009.08.015_bib56","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s00213-003-1462-6","article-title":"Driving ability after acute and sub-chronic administration of levocetirizine and diphenhydramine: A randomized, double-blind, placebo-controlled trial","volume":"169","author":"Verster","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.clinthera.2009.08.015_bib57","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1399-3038.2007.00558.x","article-title":"Safety of levocetirizine in young atopic children: An 18-month study","volume":"18","author":"Simons","year":"2007","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.clinthera.2009.08.015_bib58","series-title":"Drug Topics Red Book","article-title":"Rx product listings","author":"Hogge","year":"2009"},{"key":"10.1016\/j.clinthera.2009.08.015_bib60","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1398-9995.2005.00820.x","article-title":"Costs associated with persistent allergic rhinitis are reduced by levocetirizine","volume":"60","author":"Bousquet","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.clinthera.2009.08.015_bib61","first-page":"26","article-title":"Cost-effectiveness of second-generation antihistamines and mon-telukast in relieving allergic rhinitis nasal symptoms","volume":"1","author":"Goodman","year":"2008","journal-title":"Am Health Drug Benefits"},{"key":"10.1016\/j.clinthera.2009.08.015_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00044011-200626010-00001","article-title":"Cost effectiveness of levocetirizine in chronic idiopathic urticaria: A pooled analysis of two randomised controlled trials","volume":"26","author":"Kapp","year":"2006","journal-title":"Clin Drug Investig"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291809002987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291809002987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T01:57:56Z","timestamp":1685152676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291809002987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":61,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0149291809002987"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2009.08.015","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}